Emily Mullin

Dozens of Olympic athletes competed with Covid as society increasingly treats it like the flu or the common cold. Public health experts warn that it's anything but.

The agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder, pushing back its next proposal by years.

The regulatory agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder.

After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the company.

There’s now a significant chance the spacecraft's crew will have to return to Earth on a different one—and maybe not until next year.

Researchers are testing the use of mRNA to get damaged livers to repair themselves, in a move that could one day lessen the need for organ transplants.

Researchers are testing the use of mRNA to get damaged livers to repair themselves, in a move that could one day lessen the need for organ transplants.

In a trial in the Democratic Republic of the Congo, the drug tecovirimat, also known as TPOXX, was found to be no better than placebo at clearing mpox lesions.

In a trial in the Democratic Republic of the Congo, the drug tecovirimat, also known as TPOXX, was found to be no better than placebo at clearing mpox lesions.

With antibiotics losing their effectiveness, one company is turning to gene editing and bacteriophages—viruses that infect bacteria—to combat infections.